GILEAD SCIENCES/ US3755581036 /
05/04/2024 18:23:03 | Var. -4.45 | Volume | Denaro03:00:57 | Lettera03:00:57 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
64.51EUR | -6.45% | 5 Fatturato: 322.55 |
-Quantità in denaro: - | -Quantità in lettera: - | 75.36 bill.EUR | - | - |
GlobeNewswire
13:06
Key information relating to the cash dividend to be paid by Golar LNG Limited (Ticker: GLNG)
GlobeNewswire
13:03
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 a...
GlobeNewswire
13:02
Allakos Announces First Patient Dosed in Phase 1 Trial of AK006 in Chronic Spontaneous Urticaria
GlobeNewswire
13:00
4AIR Business Aviation Analysis Finds Small Changes to Aircraft Routings Could Reduce Environmental ...
Newsfile Corp
13:00
Maple Gold to Participate in the Mining Investment Event of the North, Canada's Only Tier I Global M...
GlobeNewswire
13:00
Rentschler Biopharma Appoints Patrick Meyer as Global Head BD Sales and Alliance Management
GlobeNewswire
13:00
Atha Energy Agrees to Terms on $10.7 Million Option Agreement with Riverboat Energy Corporation for ...
GlobeNewswire
13:00
Axsome Therapeutics Presents Data from Multiple Programs at the 2024 American Society of Clinical Ps...
GlobeNewswire
13:00
Presenting on the Emerging Growth Metals Mining Resources & Energy Conference on May 29 Register Now
GlobeNewswire
13:00
Nevada Exploration Forms Advisory Board and Appoints Former Uranerz Uranium Professionals
GlobeNewswire
13:00
Merus’ Petosemtamab in Combination with Pembrolizumab Interim Data Demonstrates Robust Response Rate...